Tuberculosis following PD-1 blockade for cancer immunotherapy

Due to the well-established therapeutic benefit of boosting anti-tumor responses through blockade of the T cell inhibitory receptor PD-1, it has been proposed that PD-1 blockade could be also useful in infectious disease settings, including Mycobacterium tuberculosis (Mtb) infection. However, in pre...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sci Transl Med
Main Authors: Barber, Daniel L., Sakai, Shunsuke, Kudchadkar, Ragini R., Fling, Steven P., Day, Tracey A., Vergara, Julie A., Ashkin, David, Cheng, Jonathan H., Lundgren, Lisa, Raabe, Vanessa N., Kraft, Colleen S., Nieva, Jorge J., Cheever, Martin A., Nghiem, Paul T., Sharon, Elad
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7372940/
https://ncbi.nlm.nih.gov/pubmed/30651320
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scitranslmed.aat2702
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados